Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MS INTERNATIONAL PLC Major Shareholding Notification 2021

Oct 28, 2021

7799_mrq_2021-10-28_9e0f596e-182a-4598-adcf-80cb0dde2917.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6179Q

SourceBio International PLC

28 October 2021

28 October 2021

SourceBio International plc

("SourceBio", the "Company" or the "Group")

Director/PDMR Shareholding

SourceBio International plc has been notified that on 20 October 2021, Harwood Capital LLP made the following notifiable transactions; (i) Harwood Capital LLP transferred 5,453,161 and 655,164 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Oryx International Growth Fund Limited ("Oryx") and North Atlantic Smaller Companies Investment Trust plc ("NASCIT"), respectively; and (ii) Harwood Capital LLP disposed of 1,399,517 Ordinary Shares.

Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP and has control of investment decisions in relation to Oryx and NASCIT. Following the transactions, Harwood Capital LLP and Christopher Mills are beneficially interested in 20,275,680 Ordinary Shares, representing 27.3% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Harwood Capital LLP and Harwood Management (Gibraltar) Ltd, investment managers
2 Reason for the notification
a) Position/status Christopher Mills is a non-executive director of the issuer and Chief Executive of the investment managers
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name SourceBio International Plc
b) LEI 213800KY4C9WU7WBW518
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of  £0.0015 each
Identification code GB00BKSB1674
b) Nature of the transaction (i)         Transfer of shares

(ii)        Disposal of shares
c) Price(s) and volume(s) (i)
Price(s) Volume(s)
Nil 5,453,161
Nil 655,164
(ii)
Price(s) Volume(s)
125.00p 1,339,517
d) Aggregated information
- Aggregated volume

- Price
(i)

6,108,325

Nil

(ii)
N/A - Single transaction
e) Date of the transaction 20 October 2021
f) Place of the transaction London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFSFIDLTFIL